ANTICANCER COMBINATIONS
    31.
    发明申请
    ANTICANCER COMBINATIONS 审中-公开
    反对者组合

    公开(公告)号:US20160184456A1

    公开(公告)日:2016-06-30

    申请号:US14978590

    申请日:2015-12-22

    申请人: City of Hope

    摘要: Provided herein, inter alia, are compositions and kits comprising a bacterial cell and a tumor penetrating agent. Also provided are methods of treating cancer in a subject including the step of administering to the subject an effective amount of a bacterial cell and a tumor penetrating agent. Provided are methods of stimulating an immune system in a subject. The methods include administering to the subject an effective amount of a bacterial cell and a tumor penetrating agent. Also provided are methods of enhancing delivery of an anti-cancer agent to a tumor cell including the step of contacting the tumor cell with a bacterial cell, a tumor penetrating agent and an anti-cancer agent.

    摘要翻译: 本文提供了包括细菌细胞和肿瘤渗透剂的组合物和试剂盒。 还提供了在受试者中治疗癌症的方法,包括向受试者施用有效量的细菌细胞和肿瘤渗透剂的步骤。 提供了刺激受试者中的免疫系统的方法。 所述方法包括向受试者施用有效量的细菌细胞和肿瘤渗透剂。 还提供了增强抗癌剂向肿瘤细胞递送的方法,包括使肿瘤细胞与细菌细胞,肿瘤渗透剂和抗癌剂接触的步骤。

    TUMOR ASSOCIATED VACCINES AND COMPOSITIONS FOR DISRUPTING TUMOR-DERIVED IMMUNOSUPPRESSION FOR USE IN COMBINATION CANCER IMMUNOTHERAPY
    32.
    发明申请
    TUMOR ASSOCIATED VACCINES AND COMPOSITIONS FOR DISRUPTING TUMOR-DERIVED IMMUNOSUPPRESSION FOR USE IN COMBINATION CANCER IMMUNOTHERAPY 有权
    肿瘤相关疫苗和组合物,用于破坏用于组合癌肿瘤免疫治疗的肿瘤衍生免疫抑制

    公开(公告)号:US20140186401A1

    公开(公告)日:2014-07-03

    申请号:US14065284

    申请日:2013-10-28

    申请人: CITY OF HOPE

    IPC分类号: C12N15/113

    摘要: In one embodiment, a single modality cancer immunotherapy regimen that includes a therapeutic composition is provided. Such a therapeutic composition may include a Salmonella strain comprising a plasmid that expresses an shRNA molecule that suppresses the expression of an immunosuppressive target and suppresses tumor growth. In some aspects, the Salmonella strain is an attenuated Salmonella typhimurium strain. In other aspects, the immunosuppressive target is STAT3, IDO1, IDO2, Arginase 1, iNOS, CTLA-4, TGF-β, IL-10, pGE2 or VEGF. In one embodiment, the immunosuppressive target is IDO1 or Arg1 and the shRNA molecule is any one of SEQ ID NO:5-14.

    摘要翻译: 在一个实施方案中,提供了包括治疗组合物的单一模态癌免疫治疗方案。 这样的治疗组合物可以包括沙门氏菌菌株,其包含表达抑制免疫抑制靶的表达并抑制肿瘤生长的shRNA分子的质粒。 在一些方面,沙门氏菌属菌株是减毒的鼠伤寒沙门氏菌菌株。 在其他方面,免疫抑制靶标是STAT3,IDO1,IDO2,精氨酸酶1,iNOS,CTLA-4,TGF-和bgr,IL-10,pGE2或VEGF。 在一个实施方案中,免疫抑制靶是IDO1或Arg1,shRNA分子是SEQ ID NO:5-14中的任一个。